3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase EARLY_PHASE1
1
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
36
Prostatic Neoplasms
27
Carcinoma, Non-Small-Cell Lung
14
Lymphoma
13
Rectal Neoplasms
11
Lung Neoplasms
11
Head and Neck Neoplasms
11
Recurrence
10
Neoplasms
10
Neoplasm Metastasis
9
Carcinoma, Hepatocellular
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Esophageal Squamous Cell Carcinoma
8
Esophageal Neoplasms
8
Uterine Cervical Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
7
Lymphoma, Non-Hodgkin
7
Lymphoma, Large B-Cell, Diffuse
7
Leukemia
7
Central Nervous System Neoplasms
7
Brain Neoplasms
7
Multiple Myeloma
6
Hyperthermia
6
Carcinoma, Intraductal, Noninfiltrating
6
Lymphoma, Follicular
5
Hodgkin Disease
5
Glioblastoma
5
Dendritic Cell Sarcoma, Interdigitating
5
Congenital Abnormalities
5
Colorectal Neoplasms
5
Interventions
Zolpidem
1
Venlafaxine Hydrochloride
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiation
1
Proton Therapy
1
Magnetic Resonance Spectroscopy
1
Counseling
1
Chemotherapy, Adjuvant
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Carcinoma, Lobular
×
Radiotherapy
×
Clear all
NCT01819233
2025-06-06
CAREFOR
Thomas Jefferson University
Phase NA
Completed
38 enrolled
10 charts